ROSANA CAMARA AGONDI

(Fonte: Lattes)
Índice h a partir de 2011
10
Lattes
ORCID
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/60 - Laboratório de Imunologia Clínica e Alergia, Hospital das Clínicas, Faculdade de Medicina
LIM/19 - Laboratório de Histocompatibilidade e Imunidade Celular, Hospital das Clínicas, Faculdade de Medicina

Filtros

Mostrar mais
Limpar filtros

Configurações

search.filters.applied.f.dateIssued: 2021 ×

Resultados de Busca

Agora exibindo 1 - 10 de 19
  • bookPart
    Controle de exposição ambiental
    (2021) SOUZA, Bárbara de; GALVãO, Clóvis Eduardo Santos; AGONDI, Rosana Câmara
  • conferenceObject
    Anaphylaxis during skin prick test with aeroallergen extract: Case report
    (2021) OLIVEIRA, I. A.; PRADO, A. I. F.; ALBERTO, N. E. S.; MENECHINO, N. T. C.; KALIL, J.; GIAVINA-BIANCHI, P.; AGONDI, R. C.
  • bookPart
    Terapia monoclonal nas doenças alérgicas
    (2021) AGONDI, Rosana Câmara; GIAVINA-BIANCHI, Pedro; KALIL FILHO, Jorge Elias
  • bookPart
    Urticária
    (2021) AGONDI, Rosana Câmara; ALMONFREY, Franciane Bruschi; MOTTA, Antonio Abílio
  • bookPart
    Angioedema
    (2021) MOTTA, Antonio Abílio; AGONDI, Rosana Câmara
  • article 54 Citação(ões) na Scopus
    The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
    (2021) KOCATURK, Emek; SALMAN, Andac; CHERREZ-OJEDA, Ivan; CRIADO, Paulo Ricardo; PETER, Jonny; COMERT-OZER, Elif; ABUZAKOUK, Mohamed; AGONDI, Rosana Camara; AL-AHMAD, Mona; ALTRICHTER, Sabine; ARNAOUT, Rand; ARRUDA, Luisa Karla; ASERO, Riccardo; BAUER, Andrea; BEN-SHOSHAN, Moshe; BERNSTEIN, Jonathan A.; BIZJAK, Mojca; BOCCON-GIBOD, Isabelle; BONNEKOH, Hanna; BOUILLET, Laurence; BRZOZA, Zenon; BUSSE, Paula; CAMPOS, Regis A.; CARNE, Emily; CONLON, Niall; CRIADO, Roberta F.; LIMA, Eduardo M. de Souza; DEMIR, Semra; DISSEMOND, Joachim; GUNAYDIN, Sibel Dogan; DOROFEEVA, Irina; ENSINA, Luis Felipe; ERTAS, Ragip; FERRUCCI, Silvia Mariel; FIGUERAS-NART, Ignasi; FOMINA, Daria; FRANKEN, Sylvie M.; FUKUNAGA, Atsushi; GIMENEZ-ARNAU, Ana M.; GODSE, Kiran; GONCALO, Margarida; GOTUA, Maia; GRATTAN, Clive; GUILLET, Carole; INOMATA, Naoko; JAKOB, Thilo; KARAKAYA, Gul; KASPERSKA-ZAJAC, Alicja; KATELARIS, Constance H.; KOSNIK, Mitja; KRASOWSKA, Dorota; KULTHANAN, Kanokvalai; KUMARAN, M. Sendhil; LANG, Claudia; LARCO-SOUSA, Jose Ignacio; LAZARIDOU, Elisavet; LESLIE, Tabi Anika; LIPPERT, Undine; LLOSA, Oscar Calderon; MAKRIS, Michael; MARSLAND, Alexander; V, Iris Medina; MESHKOVA, Raisa; PALITOT, Esther Bastos; PARISI, Claudio A. S.; PICKERT, Julia; RAMON, German D.; RODRIGUEZ-GONZALEZ, Monica; ROSARIO, Nelson; RUDENKO, Michael; RUTKOWSKI, Krzysztof; SANCHEZ, Jorge; SCHLIEMANN, Sibylle; SEKEREL, Bulent Enis; SERPA, Faradiba S.; SERRA-BALDRICH, Esther; SONG, Zhiqiang; SORIA, Angele; STAEVSKA, Maria; STAUBACH, Petra; TAGKA, Anna; TAKAHAGI, Shunsuke; THOMSEN, Simon Francis; TREUDLER, Regina; VADASZ, Zahava; VALLE, Solange Oliveira Rodrigues; DOORN, Martijn B. A. Van; VESTERGAARD, Christian; WAGNER, Nicola; WANG, Dahu; WANG, Liangchun; WEDI, Bettina; XEPAPADAKI, Paraskevi; YUCEL, Esra; ZALEWSKA-JANOWSKA, Anna; ZHAO, Zuotao; ZUBERBIER, Torsten; MAURER, Marcus
    Introduction The COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown. Aim To understand how CU patients are affected by the COVID-19 pandemic; how specialists alter CU patient management; and the course of CU in patients with COVID-19. Materials and Methods Our cross-sectional, international, questionnaire-based, multicenter UCARE COVID-CU study assessed the impact of the pandemic on patient consultations, remote treatment, changes in medications, and clinical consequences. Results The COVID-19 pandemic severely impairs CU patient care, with less than 50% of the weekly numbers of patients treated as compared to before the pandemic. Reduced patient referrals and clinic hours were the major reasons. Almost half of responding UCARE physicians were involved in COVID-19 patient care, which negatively impacted on the care of urticaria patients. The rate of face-to-face consultations decreased by 62%, from 90% to less than half, whereas the rate of remote consultations increased by more than 600%, from one in 10 to more than two thirds. Cyclosporine and systemic corticosteroids, but not antihistamines or omalizumab, are used less during the pandemic. CU does not affect the course of COVID-19, but COVID-19 results in CU exacerbation in one of three patients, with higher rates in patients with severe COVID-19. Conclusions The COVID-19 pandemic brings major changes and challenges for CU patients and their physicians. The long-term consequences of these changes, especially the increased use of remote consultations, require careful evaluation.
  • article 3 Citação(ões) na Scopus
    Clinical, functional and inflammatory evaluation in asthmatic patients after a simple short-term educational program: a randomized trial
    (2021) FELIX, Soraia Nogueira; AGONDI, Rosana Camara; AUN, Marcelo Vivolo; OLIVO, Clarice Rosa; ALMEIDA, Francine Maria de; AMORIM, Thais Santos; CEZARIO, Julia Caroline; GIAVINA-BIANCHI, Pedro; TIBERIO, Iolanda de Fatima Lopes Calvo; MARTINS, Milton de Arruda de; ROMANHOLO, Beatriz Mangueira Saraiva
    This study aimed to evaluate the clinical evolution, functional parameters and inflammatory activity of asthma in patients who submitted to an educational intervention. 58 adult patients over 18 years of age with partly controlled and uncontrolled asthma were randomized into an intervention group (IG) (N = 32) and a control group (CG) (N = 26) and evaluated for 12 weeks. The Asthma Control Test (ACT), Asthma Control Questionnaire (ACQ), Asthma Quality Life Questionnaire (AQLQ) and Beck Depression Inventory (BDI) questionnaires were applied. Spirometry, exhaled nitric oxide (NO), exhaled breath condensate (EBC) and induced sputum (IS), measurement of the peak flow and symptoms were performed. The IG patients received an educational activity for 30 min applied by a nurse. Statistical analysis: analysis of variance with repeated intragroup measures. IG presented a decreased number of eosinophils in IS and IL-17A in EBC, an increase in the percentage of FEV1 before and after bronchodilator and an improvement in quality of life compared to the CG. There was an improvement in depression levels and a decrease in IL-4 and IL-5 in the IS and in the EBC in both groups. Our results suggest that an educational intervention can bring benefits concerning the control of inflammation, lung function alterations, quality of life and levels of depression in asthmatic patients. Registration: ClinicalTrials.gov; NCT03655392.
  • bookPart
    Tosse no adulto
    (2021) ASSIS, João Paulo; TAKEJIMA, Priscila; AGONDI, Rosana Câmara
  • conferenceObject
    Clinical conditions of patients with chronic urticaria during the pandemic caused by the 2019 Novel Coronavirus Disease (COVID-19)
    (2021) ARGOLO, Paula; PEREIRA, Grazielly; PEREIRA, G. F.; KALIL, Jorge; MOTTA, Antonio; AGONDI, Rosana
  • conferenceObject
    Difference in clinical characteristics of patients with common variable immunodeficiency (CVID) according to pulmonary alterations - A cohort of 182 patients from a Brazilian tertiary hospital
    (2021) FRANCO, Priscila; AGONDI, Rosana; PEREIRA, Grazielly; PEREIRA, G. F.; GRECCO, Octavio; MARINHO, Ana Karolina; BARROS, Myrthes Toledo; BARROS, Myrthes T.; KALIL, Jorge; KOKRON, Cristina